A Randomized, Open-label, Parallel-group, Active-control PK/PD Study of Three Doses of Leuprolide Oral Tablets in Comparison to an IM Dose of Leuprolide in Healthy Female Volunteers
Phase of Trial: Phase II
Latest Information Update: 27 Jun 2018
At a glance
- Drugs Leuprorelin (Primary) ; Leuprorelin
- Indications Endometriosis
- Focus Pharmacodynamics
- Sponsors Enteris BioPharma
- 26 Jun 2018 According to an Enteris BioPharma media release,company announced positive results fro this trial
- 18 Jun 2018 Status changed from active, no longer recruiting to completed.
- 30 Apr 2018 According to an Enteris BioPharma media release, Status changed from recruiting to active, no longer recruiting.